Fig. 2

Effect of BPJ, atosiban, and the combination of BPJ with atosiban on human myometrial contractility in vitro. BPJ (green; 15 μL), atosiban (blue; 4.3 μL of 375 μg/mL) or their combination (red, same concentrations) were added to the myograph chamber. The scatter dot plot shows the AUC (a), the amplitude (b), and the frequency (c) of contractions expressed as percentage of initial. Krebs solution was used as negative control (black, 5 μL). Data were obtained from 11 to 15 different biopsies (n = 11–15) and are presented as mean value ± SEM. *p < 0.05